Virginia Retirement Systems Et Al Invitae Corp Transaction History

Virginia Retirement Systems Et Al

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$14.7 - $28.67 $205,800 - $401,380	-14,000 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$24.31 - $33.6 $55,913 - $77,280	2,300 Added 19.66%	14,000 $398,000
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $221,765 - $343,400	-8,500 Reduced 42.08%	11,700 $395,000
Q1 2021 Apr 30, 2021	BUY	$33.06 - $56.93 $39,672 - $68,316	1,200 Added 6.32%	20,200 $772,000
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $261,903 - $384,580	6,700 Added 54.47%	19,000 $794,000

Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $349,689 - $549,441	12,300 New	12,300 $533,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.